BRPI0908266A2 - Solução substituta do sangue - Google Patents

Solução substituta do sangue

Info

Publication number
BRPI0908266A2
BRPI0908266A2 BRPI0908266-2A BRPI0908266A BRPI0908266A2 BR PI0908266 A2 BRPI0908266 A2 BR PI0908266A2 BR PI0908266 A BRPI0908266 A BR PI0908266A BR PI0908266 A2 BRPI0908266 A2 BR PI0908266A2
Authority
BR
Brazil
Prior art keywords
blood substitute
substitute solution
solution
blood
substitute
Prior art date
Application number
BRPI0908266-2A
Other languages
English (en)
Inventor
Hemant Thatte
Original Assignee
Harvard College
Us Dept Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Us Dept Veterans Affairs filed Critical Harvard College
Publication of BRPI0908266A2 publication Critical patent/BRPI0908266A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0908266-2A 2008-02-15 2009-02-10 Solução substituta do sangue BRPI0908266A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6594908P 2008-02-15 2008-02-15
PCT/US2009/000831 WO2009105164A2 (en) 2008-02-15 2009-02-10 Blood substitute solution

Publications (1)

Publication Number Publication Date
BRPI0908266A2 true BRPI0908266A2 (pt) 2015-07-21

Family

ID=40986089

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908266-2A BRPI0908266A2 (pt) 2008-02-15 2009-02-10 Solução substituta do sangue

Country Status (9)

Country Link
US (1) US8563233B2 (pt)
EP (1) EP2252281A4 (pt)
JP (1) JP2011512350A (pt)
CN (1) CN102088968A (pt)
AU (1) AU2009215883A1 (pt)
BR (1) BRPI0908266A2 (pt)
CA (1) CA2715634A1 (pt)
IL (1) IL207593A0 (pt)
WO (1) WO2009105164A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20120368A1 (it) * 2012-07-30 2014-01-31 Ambiotec Sas Composizione in grado di agire sul regolatore del muscolo myod e sulla proliferazione degli osteoblasti
WO2014117176A1 (en) * 2013-01-28 2014-07-31 Lopez Hector L Methods of improving tolerability, pharmacodynamics, and efficacy of b-alanine and use therefor
WO2014183134A1 (en) * 2013-05-10 2014-11-13 President And Fellows Of Harvard College Solutions for red blood cells
CN109662975A (zh) * 2017-10-16 2019-04-23 文明祥 一种血液净化置换液
US12419850B1 (en) 2024-03-21 2025-09-23 GanD, Inc. Bioactive fluid compositions

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256834A (en) 1979-04-09 1981-03-17 Syva Company Fluorescent scavenger particle immunoassay
EP0054635B1 (de) * 1980-12-23 1985-02-13 Dr. Franz Köhler Chemie GmbH Protektive Lösung für Herz und Niere und Verfahren zu deren Herstellung
IT1214598B (it) 1985-04-17 1990-01-18 Schiapparelli Farma Uso terapeutico della fosfocreatina.
US4879283A (en) 1985-10-03 1989-11-07 Wisconsin Alumni Research Foundation Solution for the preservation of organs
US4798824A (en) 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US5243044A (en) * 1986-08-25 1993-09-07 International Therapeutics, Inc. Compounds of perfluoro[3,3,3]propellene and perfluoro hexamethylenetetramine
US5130230A (en) * 1988-05-02 1992-07-14 Cryomedical Sciences, Inc. Blood substitute
US5075210A (en) 1989-12-21 1991-12-24 The Regents Of The University Of California Preservation of the heart for transplantation
WO1992011773A1 (en) 1990-12-31 1992-07-23 University Of Florida Compositions and methods for achieving improved physiological response to exercice
US5200398A (en) 1991-09-12 1993-04-06 Mount Sinai Hospital Corporation Composition for the preservation of organs comprising glucuronic acid or a physiologically tolerated salt or ester thereof
US5279937A (en) 1992-04-30 1994-01-18 Detechnology Canada Use of macroglobulins to improve the signal-to-background ratio in affinity binding assays
US5945272A (en) * 1993-06-04 1999-08-31 Biotime, Incorporated Plasma expanders and blood substitutes
US6680305B1 (en) * 1993-06-04 2004-01-20 Biotime, Inc. Physiologically acceptable aqueous solutions and methods for their use
US5536751A (en) * 1994-05-09 1996-07-16 The United States Of America As Represented By The Secretary Of The Army Pharmaceutical alpha-keto carboxylic acid compositions method of making and use thereof
US5554497A (en) * 1994-12-12 1996-09-10 Charlotte-Mecklenburg Hospital Authority Cardioplegic solution for arresting an organ
US6028107A (en) 1997-02-27 2000-02-22 Waugh; William Howard Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
US6100082A (en) 1997-09-23 2000-08-08 Hassanein; Waleed H. Perfusion apparatus and method including chemical compositions for maintaining an organ
US6153582A (en) 1998-11-05 2000-11-28 Bausch & Lomb Surgical, Inc. Defined serumfree medical solution for ophthalmology
FR2785501B1 (fr) 1998-11-10 2001-01-05 Centre Nat Rech Scient Solution de perfusion et/ou de conservation et/ou de reperfusion lors de la transplantation d'organes
US20040038192A1 (en) 1999-04-14 2004-02-26 Breonics, Inc. System for exsanguinous metabolic support of an organ or tissue
KR20020059255A (ko) * 1999-06-17 2002-07-12 린다 에스. 스티븐슨 저온 저장을 개선하기 위한 ＰＥＧ-Ｈｂ를 사용하는 연속심장 관류 보존
CA2388934A1 (en) 1999-10-26 2001-05-03 Bio-Hydration Research Lab, Inc. Micro-cluster liquids and methods of making and using them
US6492103B1 (en) 2000-01-31 2002-12-10 Organ Recovery Systems, Inc. System for organ and tissue preservation and hypothermic blood substitution
US6569615B1 (en) * 2000-04-10 2003-05-27 The United States Of America As Represented By The Department Of Veteran's Affairs Composition and methods for tissue preservation
AU2001276963A1 (en) 2000-07-19 2002-01-30 Neuron Therapeutics, Inc. Kits and compositions supporting intracranial perfusions
SE0002832D0 (sv) * 2000-08-07 2000-08-07 Jostra Ab Cardioplegic solution
US20020132220A1 (en) 2000-12-27 2002-09-19 Berens Kurt L. Use of selectin antagonists in organ preservation solutions
US6310094B1 (en) * 2001-01-12 2001-10-30 Baxter International Inc. Ready-to-use esmolol solution
ITRM20010337A1 (it) 2001-06-14 2002-12-16 Sigma Tau Ind Farmaceuti Soluzione per la conservazione e perfuzione di organi in attesa che vengano trapiantati.
US20030124503A1 (en) * 2001-12-28 2003-07-03 Olivencia-Yurvati Albert H. Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof
US7109169B2 (en) * 2002-06-28 2006-09-19 Hobai Ion A Method for treating heart failure by inhibiting the sarcolemmal sodium/calcium exchange
CA2519488A1 (en) 2003-03-20 2004-10-07 Aquaphotonics, Inc. Micro-cluster compositions
GB0311256D0 (en) 2003-05-16 2003-06-18 Bishop Gordon W Case with seat
US7087369B2 (en) 2003-12-17 2006-08-08 The Regents Of The University Of California Cornea preservation medium
US7678888B2 (en) 2004-04-21 2010-03-16 Albert Einstein College Of Medicine Of Yeshiva University Stable oxidation resistant powdered hemoglobin, methods of preparing same, and uses thereof
NZ591524A (en) 2004-10-07 2012-09-28 Transmedics Inc Method for timing pulsatile flow of normothermic perfusate to the heart in ex-vivo organ care
US9301519B2 (en) * 2004-10-07 2016-04-05 Transmedics, Inc. Systems and methods for ex-vivo organ care
CA2590119A1 (en) 2004-12-13 2006-06-22 Aquaphotonics, Inc. Anti-aging methods and composition
WO2006133273A2 (en) 2005-06-06 2006-12-14 Aquaphotonics, Inc. Device and method for mixing liquids and oils or particulate solids and mixtures generated therefrom
US7575856B2 (en) 2005-10-28 2009-08-18 The United States Of America As Represented By The Department Of Veterans Affairs Compositions and methods for the evaluation and resuscitation of cadaveric hearts for transplant
US7763607B2 (en) 2006-04-27 2010-07-27 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
WO2008016937A2 (en) 2006-07-31 2008-02-07 Aquaphotonics, Inc. Device and method for combining oils with other fluids and mixtures generated therefrom
CN105123670B (zh) 2007-02-17 2018-12-14 哈佛学院董事会 用于进行组织保存的组合物以及方法

Also Published As

Publication number Publication date
IL207593A0 (en) 2010-12-30
CA2715634A1 (en) 2009-08-27
EP2252281A4 (en) 2011-08-24
US20110091863A1 (en) 2011-04-21
US8563233B2 (en) 2013-10-22
EP2252281A2 (en) 2010-11-24
AU2009215883A1 (en) 2009-08-27
CN102088968A (zh) 2011-06-08
WO2009105164A3 (en) 2009-11-05
JP2011512350A (ja) 2011-04-21
AU2009215883A8 (en) 2010-09-09
WO2009105164A2 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
NO2024044I1 (no) Insulin icodec
NO2024055I1 (no) Vibegron
EP2296593A4 (en) MEDICAL HEAD COVER
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
PL2452709T3 (pl) Kaniula
BRPI0916763A2 (pt) dialisador
EP2479575A4 (en) BLOOD GLUCOSE METER
EP3858416C0 (en) Catheter system
DE602009000580D1 (de) Endoskopsystem
EP2263545A4 (en) sonographer
EP2258421A4 (en) MEDICAL INSTRUMENT
EP2311518A4 (en) MEDICAL INSTRUMENT
EP3115072C0 (en) BLOOD TANK
DK2837348T3 (da) Kryokirurgiske fremgangsmåder
BRPI0915822A2 (pt) dispositivo médico
DK1987765T3 (da) Oximeter
EP2230301A4 (en) NEW GLUCOSE DEHYDROGENASE
DK2245463T3 (da) Diagnostisk fremgangsmåde
FR2937857B1 (fr) Membrane chirurgicale antiadherence
HRP20160577T1 (hr) Liječenje osteoartritisa
DK2346559T3 (da) Medicinsk anordning
DK2323933T3 (da) Stableenhed
EP2311340A4 (en) MEDICAL FOOTWEAR
IL207593A0 (en) Blood substitute solution
FI20085670A0 (fi) Kiinnirullain

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.